Pathological Myopia

• CLINICAL_TRIALS trial_result · 2019-03-11
  Clinical Trial Update: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization [Phase 4]

  Phase 4 trial update on dosing strategy for intravitreal ranibizumab in choroidal neovascularization associated with pathological myopia.

• CLINICAL_TRIALS trial_result · 2013-10-18
  Clinical Trial Update: Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]

  Phase 3 trial assessing ranibizumab for visual impairment due to choroidal neovascularization from pathologic myopia; completed with results…

• CLINICAL_TRIALS trial_result · 2009-02-03
  Clinical Trial Update: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) [Phase 1]

  Phase 1 trial evaluating bevacizumab (Avastin) infusion for choroidal neovascularization not associated with age-related macular degeneratio…